Managing Directors Dr. Boris Nikolic and Julie Sunderland have invested together in emerging technology, health care, and life science ventures since 2010. They combine scientific and financial expertise with an established network of leading academics, pharma executives, and venture capital firms. Once invested, they take an active role with portfolio companies, supporting startups with hiring, intellectual property, regulatory issues, and exit strategy.